Perea-Bello, Ana Helena http://orcid.org/0000-0002-4899-8389
Trapero-Bertran, Marta http://orcid.org/0000-0002-9233-1776
Dürsteler, Christian http://orcid.org/0000-0003-0840-2787
Funding for this research was provided by:
Universitat de Barcelona
Article History
Accepted: 31 October 2023
First Online: 27 December 2023
Declarations
:
: Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.
: Universitat de Barcelona supports Open Access publishing through the CRUE-CSIC Agreement.
: Ana Helena Perea-Bello, Marta Trapero-Bertran and Christian Dürsteler have no conflicts of interest that are directly relevant to the content of this article. Disclosure forms provided by the authors are available upon request.
: This SLR is part of a project approved by the following ethical research committees: Comité de Ética de la Investigación con Medicamentos del Hospital Clínic de Barcelona, 8 October 2021/Reg. HCB/2021/0986; Comitè d’ètica d’Investigació amb Medicaments, IDIAPJordiGol, 23 February 2022/Codi CEIm: 22/006-P; and registered in: PROSPERO, ID: CRD42021250086 (created 4 April 2021) and ClinicalTrials.gov ID: NCT05412784 (created 9 June 2022).
: Not applicable.
: Not applicable.
: The final dataset is available on request.
: Not applicable.
: All authors were involved in the conception and planning of the SLR. AHPB conducted the literature search, and AHPB, MTB and CD performed the screening. AHPB interpreted and synthesised the review results and wrote the paper’s first draft. MTB and CD contributed to the critical review, revisions and final draft corrections. All authors approved the final submitted version of the manuscript.